AACR Annual Meeting 2023 AACR 2023: Neoadjuvant Durvalumab Plus Chemotherapy Followed by Adjuvant Durvalumab in Patients With Resectable NSCLC
Neuro-oncology Improving T-Cell Engager Efficacy in Glioblastoma With Multi-Antigen Targeting and Novel Delivery Approaches
Lung Cancer Lung Cancer Disparities in the United States: The Role of Smoking, Comorbidities, Socioeconomic Status, and Regional Variation
